Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): Correlation with decreased expression of secretory leukocyte protease inhibitor

Journal of Investigative Dermatology

Volumn 126, Issue 4, 2006, Pages 890-901

  Thuraisingam, Thusanth ^a   Sam, Hakeem ^b   Moisan, Jacques ^a   Zhang, Yi ^c   Ding, Aihao ^d   Radzioch, Danuta ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SOLUTE CARRIER PROTEIN 11A1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT GENE; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; WOUND HEALING IMPAIRMENT;

ANIMALS; CATION TRANSPORT PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION; MACROPHAGES; MICE; MICE, KNOCKOUT; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RNA, MESSENGER; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SKIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 33645029187     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700182     Document Type: Article

References (48)

1. Ables GP, Takamatsu D, Noma H, El-Shazly S, Jin HK, Taniguchi T et al. (2001) The roles of Nramp1 and Tnfa genes in nitric oxide production and their effect on the growth of Salmonella typhimurium in macrophages from Nramp1 congenic and tumor necrosis factor-alpha-/-mice. J Interferon Cytokine Res 21:53-62
2. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T et al. (2000) Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 6:1147-53
3. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE et al. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1:260-6
4. Baqui AA, Meiller TF, Falkler WA Jr (1999) Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 6:808-11
5. Barrera LF, Kramnik I, Skamene E, Radzioch D (1994) Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-gamma and infection with BCG. Immunology 82:457-64
6. Barrera LF, Kramnik I, Skamene E, Radzioch D (1997) I-A beta gene expression regulation in macrophages derived from mice susceptible or resistant to infection with M. bovis BCG. Mol Immunol 34:343-55
7. Barton CH, Whitehead SH, Blackwell JM (1995) Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol Med 1:267-79
8. Blasi E, Radzioch D, Merletti L, Varesio L (1989) Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus. Cancer Biochem Biophys 10:303-17
9. Bradley DJ, Taylor BA, Blackwell J, Evans EP, Freeman J (1979) Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol 37:7-14
10. Canonne-Hergaux F, Calafat J, Richer E, Cellier M, Grinstein S, Borregaard N et al. (2002) Expression and subcellular localization of NRAMP1 in human neutrophil granules. Blood 100:268-75
11. Chattopadhyay A, Gray LR, Patton LL, Caplan DJ, Slade GD, Tien HC et al. (2004) Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infect Immun 72:1956-63
12. Crowther M, Brown NJ, Bishop ET, Lewis CE (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70:478-90
13. Ding A, Thieblemont N, Zhu J, Jin F, Zhang J, Wright S (1999) Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages. Infect Immun 67:4485-9
14. Dipietro LA, Reintjes MG, Low QE, Levi B, Gamelli RL (2001) Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. Wound Repair Regen 9:28-33
15. Eisenberg SP, Hale KK, Heimdal P, Thompson RC (1990) Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 265:7976-81
16. Fleming MD, Trenor CC III, Su MA, Foernzler D, Beier DR, Dietrich WF et al. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16:383-6
17. Gros P, Skamene E, Forget A (1981) Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 127:2417-21
18. Gruenheid S, Cellier M, Vidal S, Gros P (1995) Identification and characterization of a second mouse Nramp gene. Genomics 25:514-525
19. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF et al. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482-8
20. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH (1996) Antibacterial activity of antileukoprotease. Infect Immun 64:4520-4
21. Jabado N, Jankowski A, Dougaprasad S, Picard V, Grinstein S, Gros P (2000) Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med 192:1237-48
22. Jin F, Nathan CF, Radzioch D, Ding A (1998) Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect Immun 66:2447-52
23. Jin FY, Nathan C, Radzioch D, Ding A (1997) Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88:417-26
24. Lai JY, Pittelkow MR (2004) Culture confluence regulates gene expression of normal human keratinocytes. Wound Repair Regen 12:613-7
25. Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V et al. (1999) Inhibition of NF-kappaB activation and augmentation of IkappaB by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 154:239-47
26. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-8
27. Low QE, Drugea IA, Duffner LA, Quinn DC, Cook DN, Rollins BJ et al. (2001) Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol 159:457-63
28. Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N et al. (2004) Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 200:1337-46
29. Matte C, Marquis JF, Blanchette J, Gros P, Faure R, Posner BI et al. (2000) Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur J Immunol 30:2555-64
30. McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM (1997) Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 90:1141-9
31. Moisan J, Wojciechowski W, Guilbault C, Lachance C, Di MS, Skamene E et al. (2001) Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele). Antimicrob Agents Chemother 45:3059-64
32. Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T et al. (2003) Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J Exp Med 197:669-74
33. Odaka C, Mizuochi T, Yang J, Ding A (2003) Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J Immunol 171:1507-14
34. Ohlsson S, Falk R, Yang JJ, Ohlsson K, Segelmark M, Wieslander J (2003) Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis. Clin Exp Immunol 131:190-6
35. Plant J, Glynn AA (1976) Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis 133:72-8
36. Puliti M, Radzioch D, Mazzolla R, Barluzzi R, Bistoni F, Blasi E (1995) Influence of the Beg locus on macrophage response to the dimorphic fungus Candida albicans. Infect Immun 63:4170-3
37. Radzioch D, Hudson T, Boule M, Barrera L, Urbance JW, Varesio L et al. (1991) Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J Leukoc Biol 50:263-72
38. Radzioch D, Kramnik I, Skamene E (1994) Molecular mechanisms of natural resistance to mycobacterial infections. Circ Shock 44:115-20
39. Sallenave JM, Si TM, Cox G, Chignard M, Gauldie J (1997) Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 61:695-702
40. Sheehan KC, Ruddle NH, Schreiber RD (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 142:3884-93
41. Supek F, Supekova L, Nelson H, Nelson N (1996) A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria. Proc Natl Acad Sci USA 93:5105-10
42. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK (1997) Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 176:300-3
43. Vidal SM, Malo D, Vogan K, Skamene E, Gros P (1993) Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73:469-85
44. Vidal SM, Pinner E, Lepage P, Gauthier S, Gros P (1996) Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol 157:3559-68
45. Wahl SM, Hunt DA, Wakefield LM, Cartney-Francis N, Wahl LM, Roberts AB et al. (1987) Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 84:5788-92
46. Wingens M, van Bergen BH, Hiemstra PS, Meis JF, van Vlijmen-Willems IM, Zeeuwen PL et al. (1998) Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol 111:996-1002
47. Wojciechowski W, DeSanctis J, Skamene E, Radzioch D (1999) Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene. J Immunol 163:2688-96
48. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM et al. (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111:867-78